confirmed the presence of multiple subtypes within these tumors in proportions similar to those identified by single-cell RNA-seq. Thus, although population-level data detect the dominant transcriptional program, they do not capture the true diversity of transcriptional subtypes within a tumor.
Intratumoral subtype heterogeneity provides potentially important insights into tumor biology. The stemness signature is strongest in individual cells conforming to the proneural (r = 0.12 to 0.68, P < 0.01, Student's t test) and classical (r = 0.26 to 0.64, P < 0.01, Student's t test) subtypes, but underrepresented in cells of the mesenchymal subtype ( Fig. 3C and fig. S22 ), which has been correlated with astrocytic differentiation (21) . In contrast, cells of the neural subtype do not correspond to either in vitro model (Fig. 3C ), but are more similar to normal oligodendrocytes (Fig.  4B ). These findings highlight parallels between intratumoral cellular heterogeneity in glioblastoma and cellular diversity in the developing brain, with respective subsets of tumor cells resembling a progenitor compartment, an astrocytic lineage, or an oligodendrocytic lineage. This analysis also revealed "hybrid" states ( Fig. 4B ) in which a single cell scored highly for two subtypes, most commonly classical and proneural (progenitor states) or mesenchymal and neural (differentiated states). These hybrid states may reflect aberrant developmental programs and/or interconversion between phenotypic states.
Finally, we examined whether subtype heterogeneity is relevant to prognosis (24) . We focused on tumors classified as proneural, controlling for IDH1 status (3, 43) and binning them into three groups: (i) pure proneural tumors without any transcriptional signal for other subtypes; (ii) low-heterogeneity tumors with modest signal for other subtypes (defined as average expression of the alternative subtype genes greater than the median value in the proneural group); and (iii) high-heterogeneity tumors with stronger signals for other subtypes (defined as greater than the 85th percentile in the proneural group). We also partitioned the proneural tumors according to the other detected subtype. We found that increased heterogeneity was associated with decreased survival (Fig. 4, C and D) . This suggests that the clinical outcome of a proneural glioblastoma is influenced by the proportion of tumor cells of alternate subtypes and emphasizes the clinical importance of intratumoral heterogeneity.
We have leveraged single-cell transcriptomics to characterize heterogeneous gene expression programs within five glioblastoma tumors and interrelate their transcriptional, functional, and (to a limited extent) genetic diversity. These findings have fundamental implications for cancer biology and therapeutic strategies, as signaling molecules relevant to targeted therapy show cellto-cell variability in expression and isoform selection. Moreover, in vivo tumor cells display a spectrum of stemness and differentiation states, variable proliferative capacity, and variable expression of quiescence markers, all of which may confound therapeutic strategies. Although population-level methods for glioblastoma classification have provided important prognostic insights, they do not recapitulate the diversity of transcriptional programs present in an individual tumor. Our analysis reveals that tumors contain multiple cell states with distinct transcriptional programs and provides inferential evidence for dynamic transitions. A better understanding of the spectrum and dynamics of cellular states in glioblastoma is thus critical for establishing faithful models and advancing therapeutic strategies that address the complexity of this disease. Primate lentiviruses exhibit narrow host tropism, reducing the occurrence of zoonoses but also impairing the development of optimal animal models of AIDS. To delineate the factors limiting cross-species HIV-1 transmission, we passaged a modified HIV-1 in pigtailed macaques that were transiently depleted of CD8 + cells during acute infection. During adaptation over four passages in macaques, HIV-1 acquired the ability to antagonize the macaque restriction factor tetherin, replicated at progressively higher levels, and ultimately caused marked CD4 + T cell depletion and AIDS-defining conditions. Transient treatment with an antibody to CD8 during acute HIV-1 infection caused rapid progression to AIDS, whereas untreated animals exhibited an elite controller phenotype. Thus, an adapted HIV-1 can cause AIDS in macaques, and stark differences in outcome can be determined by immunological perturbations during early infection.
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n humans, HIV-1 replicates well, but like other primate lentiviruses, it encounters impediments to replication in atypical host species (1) (2) (3) . This fact has limited the development of optimal animal models of AIDS (4, 5). To delineate the requirements for primate lentivirus to colonize a divergent host and to aid development of better animal models of AIDS, we adapted HIV-1 to replicate efficiently and cause AIDS in a monkey species.
We inoculated pigtailed macaques (Maccaca nemestrina), which lack an HIV-1-restricting TRIM5 protein (6-9), with HIV-1 clones encoding SIV MAC Vif (where SIV is simian immunodeficiency virus), which antagonizes several macaque APOBEC3 proteins that would otherwise restrict HIV-1 replication (10) (see supplementary materials and methods). The inoculum contained four clonal HIV-1 NL4-3 -derived viruses, each encoding a gp120 envelope protein from a prototype HIV-1 strain that uses the CCR5 coreceptor (Fig. 1A and fig. S1 ). In two passage-1 (P1) animals, acute plasma viremia reached~10 5 viral RNA (vRNA) copies/ml and declined thereafter (Fig. 1B) . This outcome was similar to our previous findings with an HIV-1 derivative encoding an envelope protein (KB9) that primarily uses CXCR4 (11) . One P1 animal (P1-A), in which viremia of~10 3 vRNA copies/ml was maintained for 32 weeks (Fig. 1B) , was treated with a monoclonal antibody to deplete CD8 + T cells (anti-CD8) to relieve immune pressure and thereby increase the viral population size. This animal's blood was used to initiate P2 infection (Fig. 1, A and B, and fig. S2 ). For P2 and each passage thereafter, we treated recipient animals with anti-CD8, at the time of inoculation and 1 week later, to augment early viremia (12) . This treatment caused transient CD8 + T cell depletion in blood and lymph nodes, without major impact on CD8 + T cells in gut-associated lymphoid tissue (GALT) (figs. S2 and S3). In P2-A, acute viremia reached 10 6 vRNA copies/ml, declining tõ 10 4 vRNA copies/ml at 5 to 6 weeks after infection (Fig. 1B) . In P1 and P2 animals, the levels of blood CD4 + T cells appeared unperturbed ( Fig. 2A) . We inoculated animal P3-A with blood taken from P2-A at 23 weeks postinfection, whereas animal P3-B was inoculated with blood taken 1 week later, after CD8 + cell depletion of P2-A (Fig. 1, A and  B) . P3 recipients exhibited acute viremia at~10 6 to 10 7 vRNA copies/ml. Blood CD4 + T cell numbers and the proportion of CD4 + T cells in GALT decreased after infection (Fig. 2, A and B ), but these perturbations were transient or modest in magnitude. Moreover, viremia declined over the ensuing 50 to 60 weeks (Fig. 1B) . We depleted CD8 + cells in P3 macaques on three subsequent occasions ( fig. S2 ). Although transient increases in plasma viremia followed antibody administration (Fig. 1B) , neither animal exhibited disease.
We inoculated P4 animals with blood taken from either or both P3 macaques at 50 weeks postinfection (Fig. 1, A and B) . Each developed acute viremia at~10 6 to 10 7 vRNA copies/ml (Fig. 1B) . Notably, marked and sustained CD4 + T cell depletion occurred in the blood of two out of three P4 animals and in the GALT of all P4 animals (Fig. 2,  A to C lymph nodes (fig. S4, B to D) . In P4-C, pathology was especially evident, and viremia continued to increase after the acute phase, approaching~10 8 vRNA copies/ml (Fig. 1B) . Loss of blood and GALT CD4 + T cells in P4-C was virtually complete at 28 weeks (Fig. 2, A to C) . At this point, P4-C succumbed to an AIDS-defining, multifocal extranodal B cell lymphoma with large retro-orbital and paraspinal tumors and extensive epicardial and renal involvement (Fig. 2D and fig. S5, A to C) . Such tumors, associated with SIV-induced AIDS in macaques, have been linked to opportunistic lymphocryptoviruses or rhadinoviruses and are analogous to B cell neoplasms in humans coinfected with HIV-1 and Kaposi's sarcoma-associated herpesvirus (13) . We also detected AIDS-defining Pneumocystis pneumonia in P4-C lung biopsies (Fig. 2E ), but not in controls ( fig. S6A) .
To confirm that HIV-1 had adapted to replicate efficiently and cause AIDS in macaques, we inoculated four animals (P5-A-D) (Fig. 1A) with blood from P4-C. Two macaques that were transiently depleted of CD8 + cells at inoculation (P5-C and P5-D) (Fig. 1A and fig. S2 ) developed persistently high viremia (~10 7 vRNAcopies/ml) with blood and GALT CD4 + T cell depletion (Figs. 1B and 2A ). P5-C was euthanized at week 30 after infection, with Pneumocystis pneumonia (fig. S6B) , whereas P5-D was euthanized at week 7 after onset of severe bilateral hind limb weakness with wasting. In P5-A and P5-B, which were not CD8-depleted, acute viremia reached~10 6 vRNA copies/ml but was controlled thereafter (Fig. 1B) . Blood and GALT CD4 + T cells were depleted but recovered thereafter (Fig. 2, A and B) . Subsequent CD8 + cell depletion in P5-A and P5-B at week 23 ( fig. S2 ) caused transient increases (10 3 -fold) in viremia and blood CD4 + cell depletion in P5-A, but did not recapitulate the effect of CD8 + cell depletion during acute infection (Figs. 1B and 2A) . Rather, as CD8
+ cells recovered in P5-A and P5-B, viremia and CD4 + T cells returned to predepletion levels (Figs. 1B and 2A) .
This dichotomous outcome of HIV-1 infection was reproduced in animals that received blood from P5-C. Specifically, P6-A (no CD8 depletion) showed acute viremia that was subsequently controlled with modest and transient GALT CD4 . S2) , viremia persisted at 10 6 to 10 7 vRNA copies/ml, while blood and GALT CD4 + cells were nearly completely depleted (Figs. 1B and 2,  A and B) . P6-B was euthanized at 9 weeks with symptoms of nephropathy or glomerulonephritis (azotemia, hyperphosphatemia, hypoproteinemia, and anemia). Necropsy revealed myocardial fibrosis, lymphoid depletion with histiocytosis, and diffuse expansion of the glomerular mesangial matrix. Although not AIDS-defining, these conditions have frequently been described in human AIDS patients (14) and occasionally in SIV-infected macaques (15) .
Single viral genome amplification and sequencing (SGA) (16) (17) (18) at various points during adaptation revealed that one envelope gene in the initial inoculum (AD8) dominated the viral population in P1-A and was the only strain detected in P2 to P6 (Fig. 3A) . Env sequences in P2 to P6 macaques sampled over~3.5 years exhibited onlỹ 2% divergence from AD8. Additionally, although T cells constituted the dominant infected cell type in lymph nodes, the propensity of AD8 to infect macrophages in GALT was preserved throughout P3 to P6 ( fig. S7 , A to C). In P5-C, which succumbed after a precipitous decline in blood CD4 + T cells ( Fig. 2A) , about half of the envelope sequences had a four-amino acid deletion in the V3 loop (Fig. 3B) , a determinant of co-receptor use (19) . This deletion was associated with a change in co-receptor use, as evidenced by viral sensitivity to maraviroc (CCR5 antagonist) or AMD3100 (CXCR4 antagonist) (Fig. 3,  C and D) . Thus, HIV-1 infection in P5-C recapitulated a common feature of HIV-1 disease, namely co-receptor switching, that rarely occurs in nonhuman primate lentivirus infections (20) . The V3 loop deletion associated with CXCR4 use was not detected in P6-A or P6-B, both of which received blood from P5-C.
Although the initial virus was not restricted by TRIM5a and APOBEC3, HIV-1 Vpu does not antagonize macaque tetherin, rendering the initial inoculum sensitive to this potential host-range restriction (21, 22) . Notably, an insertion of an amino acid at position 15 in the Vpu transmembrane (TM) domain (Fig. 4A ) was detected in P1-A and was found in 100% of P2-A sequences at 52 weeks, and all sequences thereafter. Another Vpu TM mutation, V21G (Fig. 4A) , was detected in P3 animals and in all sequences from P4 onward. TM domains govern Vpu-tetherin interaction (21) , and each of the TM domain mutations contributed to the ability of Vpu 15/21 to antagonize pigtailed macaque tetherin (Fig. 4B) . We previously showed that Vpu gained the ability to antagonize human tetherin during the emergence of HIV-1 in humans (23) , and the passage of HIV-1 in pigtailed macaques apparently resulted in an analogous adaptation (Fig. 4B) .
Beginning at week 4, antibodies to HIV-1 proteins were apparent in P4-A but were not detected until week 16 after infection in P4-B, which had higher viremia and some degree of blood CD4 + T cell depletion (Figs. 1B and 2A and fig. S8 ). Animal P4-C, the first to succumb to AIDS, did not seroconvert ( fig. S8 ). In fact, each macaque that progressed to AIDS after transient CD8 depletion did not seroconvert, whereas those that were not CD8 depleted and did not progress to AIDS mounted robust antibody responses ( fig. S8) . Previously, failure to seroconvert has been associated with rapid progression in SIV infection (24) . HIV-1-induced loss of CD4 + helper T cells in CD8-depleted animals may play a role in the failure to mount an antibody response in macaques that developed AIDS (12) .
The approaches employed herein have enabled HIV-1 infection of macaques to recapitulate salient features of HIV-1 infection in humans. Our findings suggest that evasion or antagonism of antiretroviral proteins is key for the colonization of new hosts by primate lentiviruses. Because transient depletion of CD8 + cells during acute infection determined whether macaques became rapid progressors or elite controllers, our findings suggest that the immunological insult during acute HIV-1 infection can determine the subsequent clinical course. It is also possible that adaptation to the host major histocompatibility complexes and evasion of adaptive immune responses may be required for HIV-1 pathogenesis in immunologically intact hosts. Finally, because the viral strain we used contains nearly all the targets of HIV-1 vaccines and drugs, further development of a pigtailed macaque-based model could facilitate the evaluation of new clinical HIV-1 therapies, prevention strategies, and interventions for virus eradication.
